Pfizer (NYSE:PFE) churns as investors price in bigger cancer pipeline discount after Seagen drug miss
Pfizer traded near flat in early premarket hours on Wednesday after a round of heavy selling that didn’t move the price much. Shares were at $24.76 at 7:07 a.m. EDT, just 0.16% higher than Tuesday’s $24.72 close. The stock is down about 14% from its 52-week high and up around 7% from its low.